EUVIMEDEUVIMED entdecken
Crossref

The Impact of TLR4 rs41426344 Polymorphism on Ankylosing Spondylitis Disease Activity: A Study in Turkish Patients

Duygu Kirkik, Sevgi Kalkanli Tas, Betül Dogantekin, Mesut Kariksiz, Barış Gündogdu, Fatih Hacimustafaoglu, Rahime Aksoy

International Journal of Immunogenetics · 2026

DOI: 10.1111/iji.70027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Immunogenetics, 2026. Verfasst von Duygu Kirkik und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hamidiye Medicine Faculty, Department of Medical Biology, University of Health Sciences, Istanbul, Türkiye. Hauptthemen laut MEDLINE: Spondylitis, Ankylosing, Toll-Like Receptor 4, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide. Die Arbeit nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ankylosing spondylitis (AS) is a chronic inflammatory disease primarily affecting the axial skeleton and sacroiliac joints, with both genetic and environmental factors playing a role in its pathogenesis. Toll‐like receptor 4 (TLR4) has been implicated in immune response and inflammation, but its genetic variations have not been extensively studied in AS. This study investigates the association between the TLR4 rs41426344 polymorphism and AS susceptibility and disease activity in a Turkish population. A total of 200 participants (100 AS patients and 100 healthy controls) were recruited. Genotyping of the TLR4 rs41426344 (G/C) polymorphism was performed using real‐time PCR melting curve analysis. Disease activity was assessed using Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Ankylosing Spondylitis Disease Activity Score with C‐reactive protein (ASDAS‐CRP) scores. Statistical analyses were conducted to determine the association between genotypes and disease risk. The CC genotype was significantly associated with AS susceptibility, with an odds ratio (OR) of 10.000 (95% CI: 4.091–24.431, p < 0.0000001), indicating a strong genetic risk factor. Additionally, CC genotype carriers exhibited higher BASFI, BASDAI and ASDAS‐CRP scores, suggesting greater disease severity and inflammation levels. A statistically significant difference ( p < 0.05) was observed in ASDAS‐CRP scores between CC and GC genotypes This is the first study to investigate the TLR4 rs41426344 polymorphism in AS, and our findings indicate a strong association with both disease susceptibility and severity in the Turkish cohort. These findings reinforce the role of innate immunity in AS pathogenesis and suggest that TLR4 polymorphisms may serve as potential genetic markers for AS risk assessment and disease activity monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spondylitis, AnkylosingToll-Like Receptor 4Genetic Predisposition to DiseasePolymorphism, Single NucleotideHumansFemaleMaleTurkeyAdultMiddle AgedGenotypeCase-Control StudiesSeverity of Illness IndexGene FrequencyAllelesGenetic Association StudiesC-Reactive ProteinRisk Factors

Stichwörter der Autor:innen

ankylosing spondylitisimmunogeneticsinnate immunityrs41426344toll‐like receptor 4 (TLR4)

Substanzen

Toll-Like Receptor 4TLR4 protein, humanC-Reactive Protein

Autor:innen und Institutionen

  • Hamidiye Medicine Faculty, Department of Medical Biology, University of Health Sciences, Istanbul, Türkiye.
  • Hamidiye Medicine Faculty, Department of Immunology, University of Health Sciences, Istanbul, Türkiye.
  • Department of Internal Medicine, University of Health Sciences Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Türkiye.
  • Department of Orthopedic and Traumatology, University of Health Sciences, Basaksehir Cam and Sakura City Hospital, Istanbul, Türkiye.
  • Department of Rheumatology, University of Health Sciences Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Türkiye.
  • Hamidiye Vocational School of Health Services, Medical Laboratory Techniques Programme, University of Health Sciences, Istanbul, Türkiye.

Zitieren

APA

Kirkik, D., Kalkanli Tas, S., Dogantekin, B., Kariksiz, M., Gündogdu, B., Hacimustafaoglu, F., & Aksoy, R. (2026). The Impact of TLR4 rs41426344 Polymorphism on Ankylosing Spondylitis Disease Activity: A Study in Turkish Patients. International Journal of Immunogenetics. https://doi.org/10.1111/iji.70027

Vancouver

Kirkik D, Kalkanli Tas S, Dogantekin B, Kariksiz M, Gündogdu B, Hacimustafaoglu F, et al. The Impact of TLR4 rs41426344 Polymorphism on Ankylosing Spondylitis Disease Activity: A Study in Turkish Patients. International Journal of Immunogenetics. 2026. doi:10.1111/iji.70027

BibTeX
@article{Kirkik2026,
  author = {Kirkik, Duygu and Kalkanli Tas, Sevgi and Dogantekin, Betül and Kariksiz, Mesut and Gündogdu, Barış and Hacimustafaoglu, Fatih and Aksoy, Rahime},
  title = {The Impact of TLR4 rs41426344 Polymorphism on Ankylosing Spondylitis Disease Activity: A Study in Turkish Patients},
  journal = {International Journal of Immunogenetics},
  year = {2026},
  doi = {10.1111/iji.70027}
}
Kostenlos starten →